In partnership with the American Association for Cancer Research, The Mark Foundation is pleased to announce that Dr. Birgit Knoechel is the recipient of the inaugural AACR-Mark Foundation NextGen Grant for Transformative Cancer Research. This award will support Dr. Knoechel’s efforts to develop new therapies for leukemia.
Dr. Knoechel is a clinician-scientist who performs research and treats patients with pediatric leukemia. Individual leukemia cells in a single patient can vary significantly in their characteristics and behaviors. Dr. Knoechel’s lab studies how variation in a population of cancer cells can contribute to resistance to a targeted leukemia therapy. By understanding how and why these therapies fail to work, strategies can be developed to overcome resistance and successfully treat children with this type of leukemia.